MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) Institutional Ownership

13F Institutional Holders and Ownership History for Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
MPLT on Nasdaq
Shares outstanding
45,148,065
Price per share
$18.58
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
23,065,711
Total reported value
$405,121,994
% of total 13F portfolios
0.01%
Share change
+23,062,256
Value change
+$405,061,184
Number of holders
74
Price from insider filings
$18.58
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Catalyst4, Inc. 45% $361,842,414 19,697,464 Catalyst4, Inc. 28 Oct 2025
Novo Holdings A/S 8.4% 3,686,622 Novo Holdings A/S 28 Oct 2025
Forbion Growth Opportunities Fund III Cooperatief U.A. 7.1% $61,527,448 3,226,400 Forbion Growth Opportunities Fund III Cooperatief U.A. 31 Dec 2025
T. Rowe Price Investment Management, Inc. 6.2% $53,380,363 2,799,180 T. Rowe Price Investment Management, Inc. 31 Dec 2025

As of 31 Dec 2025, 74 institutional investors reported holding 23,065,711 shares of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT). This represents 51% of the company’s total 45,148,065 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NOVO HOLDINGS A/S 8.2% 3,686,622 5% $64,755,515
FCPM III SERVICES B.V. 7.1% 3,226,400 7.4% $56,671,716
T. Rowe Price Investment Management, Inc. 6.2% 2,799,180 0.03% $49,168,000
GOLDMAN SACHS GROUP INC 4.3% 1,937,168 0% $34,026,356
BlackRock, Inc. 2.4% 1,095,514 0% $19,242,704
Nan Fung Group Holdings Ltd 2.2% 971,253 15% $17,060,059
5AM Venture Management, LLC 2.1% 950,011 5.2% $16,686,943
Sanofi 2% 912,041 5.2% $16,020,000
VANGUARD GROUP INC 1.9% 869,668 0% $15,275,718
Pivotal bioVenture Partners Investment Advisor LLC 1.4% 611,447 4.2% $10,743,124
PERCEPTIVE ADVISORS LLC 1.2% 550,000 0.18% $9,660,750
Velan Capital Investment Management LP 1.2% 522,305 5.3% $9,174,288
Siren, L.L.C. 1% 450,000 0.24% $7,904,250
GEODE CAPITAL MANAGEMENT, LLC 0.86% 389,026 0% $6,834,870
Vestal Point Capital, LP 0.85% 385,000 0.25% $6,762,525
BAKER BROS. ADVISORS LP 0.81% 364,705 0.04% $6,406,043
Jain Global LLC 0.73% 327,693 0.06% $5,755,928
Blue Owl Capital Holdings LP 0.72% 327,058 1.8% $5,744,774
STATE STREET CORP 0.51% 229,484 0% $4,030,886
LAZARD ASSET MANAGEMENT LLC 0.46% 207,494 0.01% $3,644,632
Board of Trustees of The Leland Stanford Junior University 0.44% 199,233 0.71% $3,499,527
CITADEL ADVISORS LLC 0.42% 190,139 0% $3,339,792
Freestone Grove Partners LP 0.41% 183,771 0.02% $3,227,938
Tetragon Partners GP Ltd 0.36% 164,525 0.61% $2,889,882
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.33% 147,930 0% $2,598,000

Institutional Holders of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 23,065,711 $405,121,994 +$405,061,184 $17.56 74